Current Topics in Medicinal Chemistry


Allen B. Reitz
Fox Chase Chemical Diversity Center, Inc.
Doylestown, PA


Become EABM
Become Reviewer

Drug Discovery by Targeting Mutant KRAS free to download

Volume:19   Issue: 23
Pp: 2079-2080
Na Ye
DOI: 10.2174/156802661923191113144238

KRAS: A Promising Therapeutic Target for Cancer Treatment

Volume:19   Issue: 23
Pp: 2081-2097
Hai-Zhou Wu, Jia-Qi Xiao, Song-Shu Xiao* and Yan Cheng*
DOI: 10.2174/1568026619666190905164144

Targeting Mutant KRAS for Anticancer Therapy

Volume:19   Issue: 23
Pp: 2098-2113
Fengqian Chen, Martin P. Alphonse, Yan Liu and Qi Liu*
DOI: 10.2174/1568026619666190902151307

Recent Advances in Developing K-Ras Plasma Membrane Localization Inhibitors

Volume:19   Issue: 23
Pp: 2114-2127
Na Ye*, Qingfeng Xu, Wanwan Li, Pingyuan Wang and Jia Zhou*
DOI: 10.2174/1568026619666190902145116

Drug Combinatorial Therapies for the Treatment of KRAS Mutated Lung Cancers

Volume:19   Issue: 23
Pp: 2128-2142
Hao He*, Chang Xu, Zhao Cheng, Xiaoying Qian and Lei Zheng*
DOI: 10.2174/1568026619666190902150555

The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges

Volume:19   Issue: 23
Pp: 2143-2157
Yu-Ting Shao, Li Ma, Tie-Hui Zhang, Tian-Rui Xu, Yuan-Chao Ye* and Ying Liu*
DOI: 10.2174/1568026619666190828162217

Overview of Current Immunotherapies Targeting Mutated KRAS Cancers

Volume:19   Issue: 23
Pp: 2158-2175
Winfrey Pui Yee Hoo, Pui Yan Siak and Lionel L.A. In*
DOI: 10.2174/1568026619666190904163524

Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutations in the Occurrence and Treatment of Pancreatic Cancer

Volume:19   Issue: 23
Pp: 2176-2186
Ziying Zhu, Saisong Xiao, Haojie Hao*, Qian Hou* and Xiaobing Fu*
DOI: 10.2174/1568026619666190828160804